Genesco (NYSE:GCO – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.300-1.700 for the period, compared to the consensus earnings per share estimate of 1.550. The company issued revenue guidance of $2.3 billion-$2.4 billion, compared to the consensus revenue estimate of $2.3 billion.
Genesco Stock Up 0.5%
NYSE GCO opened at $22.47 on Thursday. The company has a current ratio of 1.56, a quick ratio of 0.32 and a debt-to-equity ratio of 0.19. Genesco has a 1-year low of $16.19 and a 1-year high of $44.80. The company has a 50 day moving average of $20.59 and a 200-day moving average of $30.94. The company has a market cap of $242.23 million, a price-to-earnings ratio of -9.25 and a beta of 2.14.
Genesco (NYSE:GCO – Get Free Report) last posted its quarterly earnings data on Friday, May 30th. The company reported ($2.05) EPS for the quarter, topping analysts’ consensus estimates of ($2.06) by $0.01. Genesco had a positive return on equity of 0.56% and a negative net margin of 1.13%. During the same quarter last year, the firm posted ($2.10) EPS. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. On average, equities research analysts expect that Genesco will post 0.94 earnings per share for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Analysis on GCO
Insider Buying and Selling at Genesco
In related news, major shareholder Fund 1 Investments, Llc sold 12,000 shares of Genesco stock in a transaction that occurred on Friday, March 28th. The shares were sold at an average price of $20.73, for a total transaction of $248,760.00. Following the sale, the insider now directly owns 1,097,850 shares of the company’s stock, valued at approximately $22,758,430.50. The trade was a 1.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gregory A. Sandfort purchased 10,974 shares of the firm’s stock in a transaction that occurred on Thursday, March 20th. The shares were bought at an average cost of $22.92 per share, for a total transaction of $251,524.08. Following the completion of the acquisition, the director now directly owns 26,754 shares in the company, valued at $613,201.68. The trade was a 69.54% increase in their position. The disclosure for this purchase can be found here. Company insiders own 23.11% of the company’s stock.
Institutional Trading of Genesco
A number of hedge funds have recently added to or reduced their stakes in GCO. Empowered Funds LLC lifted its stake in shares of Genesco by 5.3% in the 1st quarter. Empowered Funds LLC now owns 64,783 shares of the company’s stock valued at $1,375,000 after acquiring an additional 3,282 shares during the last quarter. Royal Bank of Canada lifted its stake in shares of Genesco by 15.4% in the 1st quarter. Royal Bank of Canada now owns 52,848 shares of the company’s stock valued at $1,122,000 after acquiring an additional 7,042 shares during the last quarter. Finally, Jones Financial Companies Lllp bought a new position in shares of Genesco in the 1st quarter valued at $26,000. Institutional investors and hedge funds own 94.51% of the company’s stock.
About Genesco
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
See Also
- Five stocks we like better than Genesco
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Alphabet Stock Analysis: What’s Next—Bull or Bear Market?
- How to Calculate Options Profits
- 3 Utilities Stocks With Big Earnings, Balanced Risk
- What is the Euro STOXX 50 Index?
- NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise
Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.